202 related articles for article (PubMed ID: 31851347)
1. Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017.
Powis KM; Huo Y; Williams PL; Kacanek D; Jao J; Patel K; Seage GR; Van Dyke RB; Chadwick EG;
JAMA Netw Open; 2019 Dec; 2(12):e1917669. PubMed ID: 31851347
[TBL] [Abstract][Full Text] [Related]
2. UK national clinical audit: management of pregnancies in women with HIV.
Raffe S; Curtis H; Tookey P; Peters H; Freedman A; Gilleece Y;
BMC Infect Dis; 2017 Feb; 17(1):158. PubMed ID: 28219333
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
Okawa S; Chirwa M; Ishikawa N; Kapyata H; Msiska CY; Syakantu G; Miyano S; Komada K; Jimba M; Yasuoka J
BMC Pregnancy Childbirth; 2015 Oct; 15():258. PubMed ID: 26459335
[TBL] [Abstract][Full Text] [Related]
5. Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004-2020: A surveillance study.
Carvalho S; Lee T; Tulloch KJ; Sauve LJ; Samson L; Brophy JC; Bitnun A; Singer J; Money D; Kakkar F; Boucoiran I;
HIV Med; 2023 Feb; 24(2):130-138. PubMed ID: 35699235
[TBL] [Abstract][Full Text] [Related]
6. Translating clinical trial results into practice: the effect of an AIDS clinical trial on prescribed antiretroviral therapy for HIV-infected pregnant women.
Turner BJ; Newschaffer CJ; Zhang D; Fanning T; Hauck WW
Ann Intern Med; 1999 Jun; 130(12):979-86. PubMed ID: 10383368
[TBL] [Abstract][Full Text] [Related]
7. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
João EC; Morrison RL; Shapiro DE; Chakhtoura N; Gouvèa MIS; de Lourdes B Teixeira M; Fuller TL; Mmbaga BT; Ngocho JS; Njau BN; Violari A; Mathiba R; Essack Z; Pilotto JHS; Moreira LF; Rolon MJ; Cahn P; Prommas S; Cressey TR; Chokephaibulkit K; Werarak P; Laimon L; Hennessy R; Frenkel LM; Anthony P; Best BM; Siberry GK; Mirochnick M
Lancet HIV; 2020 May; 7(5):e322-e331. PubMed ID: 32386720
[TBL] [Abstract][Full Text] [Related]
8. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
Mofenson LM;
MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
[TBL] [Abstract][Full Text] [Related]
9. Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US.
Zalla LC; Cole SR; Eron JJ; Adimora AA; Vines AI; Althoff KN; Silverberg MJ; Horberg MA; Marconi VC; Coburn SB; Lang R; Williams EC; Gill MJ; Gebo KA; Klein M; Sterling TR; Rebeiro PF; Mayor AM; Moore RD; Edwards JK
JAMA; 2023 Jan; 329(1):52-62. PubMed ID: 36594946
[TBL] [Abstract][Full Text] [Related]
10. Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.
Venkatesh KK; Morrison L; Livingston EG; Stek A; Read JS; Shapiro DE; Tuomala RE
Obstet Gynecol; 2018 May; 131(5):879-890. PubMed ID: 29630021
[TBL] [Abstract][Full Text] [Related]
11. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical Trial.
Frenkel LM; Morrison RL; Fuller TL; Gouvêa MI; Benamor Teixeira ML; Coombs RW; Shapiro DE; Mirochnick M; Hennessey R; Whitson K; Chakhtoura N; João EC
J Acquir Immune Defic Syndr; 2021 Dec; 88(4):361-365. PubMed ID: 34369908
[TBL] [Abstract][Full Text] [Related]
13. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
[TBL] [Abstract][Full Text] [Related]
14. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.
Griner R; Williams PL; Read JS; Seage GR; Crain M; Yogev R; Hazra R; Rich K;
AIDS Patient Care STDS; 2011 Jul; 25(7):385-94. PubMed ID: 21992592
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, Placental and Breast Milk Transfer of Antiretroviral Drugs in Pregnant and Lactating Women Living with HIV.
Hodel EM; Marzolini C; Waitt C; Rakhmanina N
Curr Pharm Des; 2019; 25(5):556-576. PubMed ID: 30894103
[TBL] [Abstract][Full Text] [Related]
16. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
17. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
Fatti G; Shaikh N; Eley B; Grimwood A
AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
[TBL] [Abstract][Full Text] [Related]
19. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children.
Yao TJ; Malee K; Zhang J; Smith R; Redmond S; Rice ML; Frederick T; Torre P; Mellins CA; Hoffman HJ; Williams PL
AIDS Patient Care STDS; 2023 Mar; 37(3):119-130. PubMed ID: 36827595
[TBL] [Abstract][Full Text] [Related]
20. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015.
Suárez-García I; González J; Berenguer J; García F; Portilla J; Muga R; Moreno S; Jarrín I;
Enferm Infecc Microbiol Clin (Engl Ed); 2019 Nov; 37(9):580-587. PubMed ID: 30982676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
